Philipp Uhl

Title: Innovations of Inventor Philipp Uhl

Introduction

Philipp Uhl is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of oral dosage forms. With a total of 3 patents, Uhl's work focuses on innovative methods that enhance drug delivery systems.

Latest Patents

Uhl's latest patents include a method of making oral dosage forms. This invention involves a process that includes reacting at least one cell-penetrating peptide (CPP), purifying CPP-lipid conjugates, and processing a lipid batch to obtain CPP-modified liposomes. The invention also encompasses oral dosage forms designed for therapeutic applications. Another significant patent is related to liposomal formulation for the oral hepatic delivery of drugs. This patent describes liposomal compositions that contain tetraether lipids (TELs) and the lipopeptide Myr-HBVpreS/2-48 (Myrcludex B). These compositions are aimed at preventing or treating hepatic disorders and enhancing the oral delivery of therapeutic agents.

Career Highlights

Philipp Uhl is affiliated with Universitat Heidelberg, where he conducts his research and development activities. His work has been instrumental in advancing the understanding and application of liposomal drug delivery systems.

Collaborations

Uhl collaborates with esteemed colleagues such as Gert Fricker and Walter Mier, contributing to a dynamic research environment that fosters innovation in pharmaceutical sciences.

Conclusion

Philipp Uhl's contributions to the field of drug delivery through his innovative patents highlight his role as a leading inventor in the pharmaceutical industry. His work continues to pave the way for advancements in therapeutic methods and drug formulations.